The term was popularised in the late 1990s by a chiropractor describing a state in which chronic stress had supposedly “exhausted” the adrenal glands, leaving them unable to make enough cortisol. The model assumed the gland itself was the problem and that a fatigued gland produced flat, low cortisol all day.

Endocrinology did not adopt the framework. In 2016, Cadegiani and Kater systematically reviewed 58 studies that tested the hypothesis — in healthy adults, in stressed populations, and in patients reporting fatigue. They found no consistent pattern, no validated diagnostic test, and no biochemical basis for a discrete “adrenal exhaustion” state. Their conclusion was unambiguous: “adrenal fatigue is still a myth.”¹

That doesn’t mean the people described by the label felt fine. The symptoms — flat energy, poor sleep recovery, mood drift, blunted morning drive — are real and common. The mistake was the explanation. The gland is not the bottleneck. The signalling system that runs it is.

Burnout has a different lineage. It was studied for decades in occupational health, and in May 2019 the WHO formally included it in the 11th revision of the International Classification of Diseases (ICD-11) as an “occupational phenomenon” resulting from chronic workplace stress that has not been successfully managed.² The diagnostic criteria are three: emotional exhaustion, cynicism or mental distance from one’s work, and reduced professional efficacy.

Burnout sits adjacent to depression and chronic fatigue but is not identical to either. Depression is a mood-disorder diagnosis with cross-domain symptoms. Chronic fatigue syndrome is a separate clinical entity with its own criteria. Burnout, by contrast, is anchored in a specific context — sustained occupational demand outpacing recovery — and the underlying biology has been mapped most clearly through the HPA axis.⁷

For the people we see in clinic — founders, executives, surgeons, partners — that distinction matters. The presentation is often: bloods clear, mood not technically depressed, performance still passable on paper, but recovery has disappeared. Sleep no longer restores. Caffeine carries the morning. The drop at 3pm is harder each year. That is not a personality issue. It is a biological signal worth measuring.

The hypothalamic–pituitary–adrenal axis is the body’s primary stress-response circuit. The hypothalamus signals the pituitary, the pituitary signals the adrenal cortex, and the adrenal cortex releases cortisol — the hormone that mobilises glucose, sharpens attention, and modulates immune tone. In a healthy curve, cortisol surges in the first 30–60 minutes after waking (the Cortisol Awakening Response, or CAR), declines through the day, and reaches its lowest point near sleep onset.

Chronic stress does not break the adrenal gland. It remodels the rhythm. Bruce McEwen’s allostatic-load framework describes how the wear-and-tear of sustained adaptation alters set-points in the brain, the immune system, and the endocrine system over time.⁸ Two-thirds of the cardiovascular and metabolic load people associate with burnout is mediated by these adaptive changes, not by acute cortisol spikes.

The diurnal curve is the most reliable readout. A 2017 meta-analysis by Adam and colleagues pooled 80 studies and found that a flatter slope from morning to evening is consistently associated with poorer health — greater inflammation, more fatigue, worse mental health, and increased risk of metabolic and cardiovascular outcomes.³ The slope is the signal. A single morning value, taken in isolation, can sit inside the reference range while the slope behind it is collapsing.

One of the reasons the “adrenal fatigue” model fell apart was that researchers expected one signature — low cortisol — and the data showed two, depending on stage and context. The earlier work-stress states tend to show elevated cortisol output, particularly an exaggerated awakening response. Penz and colleagues found hair cortisol — a 3-month integrated marker — was elevated in people meeting burnout criteria, suggesting sustained over-output rather than depletion.⁵

Later exhaustion-stage burnout, particularly in people on extended sick leave, more often shows a blunted awakening response or a flattened slope.⁶ The same axis, two opposite-looking signatures, separated by where the person sits on the trajectory. A 2023 meta-analysis of effort–reward imbalance and HPA function found that workplace stress was associated with measurable changes in cortisol output and that the cortisol-on-waking value was the most consistent marker across studies.⁷

This is the part standard testing cannot resolve. A single morning serum draw cannot tell you whether the person in front of you is in the early hyper-output stage, the late blunted-output stage, or somewhere on the transition. The full curve does.

Mapping the HPA axis requires more than one sample. Two collection types are validated in research: multi-point salivary cortisol (typically four time-points across the day plus a multi-sample first-hour series for the CAR) and 24-hour urinary cortisol with timed sub-fractions. Both reconstruct the shape of the diurnal curve and reveal the awakening response that a blood draw cannot.

The DUTCH Adrenal panel measures overall HPA output and the diurnal cortisol curve via dried urine. The separate DUTCH CAR panel measures the awakening response across the first 30–60 minutes after waking. Run together, they describe both how much cortisol the system is producing and how reactive the morning surge is. One without the other gives half the picture.

Cortisol output also doesn’t exist in isolation. Chronic HPA activation is correlated with downstream consequences that are individually measurable: low-grade systemic inflammation (hs-CRP), shifts in fasting insulin and glucose handling, and increased risk of type 2 diabetes — a 2021 meta-analysis put the pooled odds ratio at 1.8.⁹ Burnout is not just a mood-state. It tracks with measurable cardiometabolic risk.